Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V8MJ
|
|||
Former ID |
DNC011665
|
|||
Drug Name |
4-(6-Cyclopentyl-hex-3-ynyl)-1H-imidazole
|
|||
Synonyms |
CHEMBL274977; 4-(6-Cyclopentyl-hex-3-ynyl)-1H-imidazole; SCHEMBL7621345; PDSP1_000105; ZINC13795227; BDBM50070220; PDSP2_000105; GT-2286; GT 2286
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H20N2
|
|||
Canonical SMILES |
C1CCC(C1)CCC#CCCC2=CN=CN2
|
|||
InChI |
1S/C14H20N2/c1(3-7-13-8-5-6-9-13)2-4-10-14-11-15-12-16-14/h11-13H,3-10H2,(H,15,16)
|
|||
InChIKey |
XFHACGZTJUJXHB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine. Bioorg Med Chem Lett. 1998 May 19;8(10):1133-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.